TickerFactsScreenerDevelopers

Allogene Therapeutics, Inc. (ALLO) — Net Income

Annual figures by fiscal year, from SEC filings.

2018: -$211.50M2019: -$184.59M2020: -$316.38M2021: -$182.05M2022: -$340.41M2023: -$327.26M2024: -$257.59M2025: -$190.89M-$190.89M
2018Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$190.89M+25.9%
2024-$257.59M+21.3%
2023-$327.26M+3.9%
2022-$340.41M-87.0%
2021-$182.05M+42.5%
2020-$316.38M-71.4%
2019-$184.59M+12.7%
2018-$211.50M—